NIVFNasdaqServices-Misc Health & Allied Services, NECAlso trades as NIVFW

NewGenIvf Group Ltd

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026

$0.28+0.00 (+1.47%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): 0.1
Dividend yield: –

NewGenIvf Group Ltd income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	4.73	5.43	5.14	5.94	4.12
Cost of Revenue	3.77	3.61	3.45	4.41	3.09
Gross Profit	0.96	1.83	1.68	1.54	1.02
Selling, General & Admin	12	2.99	1.64	1.14	0.83
Selling & Marketing	1.19	0.21	0.02	0.04	0.02
General & Administrative	10	2.78	1.62	1.10	0.80
Operating Expenses	12	2.99	1.64	1.14	0.83
Operating Income	-11	-1.16	0.04	0.40	0.20
Interest Expense	0.62	0.77	0.05	–	–
Interest & Investment Income	0.00	0.01	0.00	0.00	0.00
Other Non-Operating Income	20	0.20	0.07	-0.05	-0.04
Gain (Loss) on Sale of Assets	-0.33	–	–	-0.11	–
Pretax Income	9.73	-0.96	0.11	0.34	0.16
Income Tax Expense	–	-0.49	–	0.21	0.29
Net Income incl. Noncontrolling Interests	9.73	-0.47	0.11	0.14	-0.14
Minority Interest in Earnings	-0.15	0.05	-0.02	-0.32	-0.14
Net Income	9.88	-0.52	0.13	0.46	0.00
EPS (Basic)(per share)	214.73	-4,408.76	13,019.30	4.72	0.00
EPS (Diluted)(per share)	3.04	-4,408.76	13,019.30	4.72	0.00
Shares Outstanding (Basic, Weighted)(shares)	0.05	0.00	0.00	0.03	0.03
Shares Outstanding (Diluted, Weighted)(shares)	3.25	0.00	0.00	0.03	0.03
EBITDA	-11	-1.14	0.07	0.50	0.37
Provision for Credit Losses	–	0.02	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin: 20.2%
Operating margin: -226.9%
Net margin: 209.0%
Return on equity, FY2025: 77.2%

Financial strength

Current ratio: 3.12
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 32.1%

Valuation

P/E ratio: 0.1
Price to sales: –
Price to book: –
Dividend yield: –